As showcased in Fig. 5, Peripheral blood FOXO3, PIK3R1 and HSPA4 expression were significantly higher in patients with allergic rhinitis after 6 months of immunotherapy, while RFC2 and POLD3 expression were not significantly different. This evidence concerns the gene RFC2 and allergic rhinitis.